José Miguel Torres Viera (@torresviera) 's Twitter Profile
José Miguel Torres Viera

@torresviera

Interventional Cardiologist. immediate past president Sociedad Venezolana de Cardiologia. Enthusiastic learner . Voracious appetite for new ideas.

ID: 54446565

linkhttp://svcardiologia.org calendar_today07-07-2009 04:14:21

44,44K Tweet

6,6K Followers

3,3K Following

Jay Mohan, D.O., FACC, FSCAI, FASE, RPVI (@drjaymohan) 's Twitter Profile Photo

RHC. Makes a difference when done right. Know the waveforms. Know the nuances. Troubleshoot. Garbage in=garbage out. When used properly your job will be easier. #Cardiotwitter Visualmed: Clinical Trials #cardiology #swanganz #rhc #Medtwitter

RHC. Makes a difference when done right. Know the waveforms. Know the nuances. Troubleshoot. Garbage in=garbage out. When used properly your job will be easier. #Cardiotwitter <a href="/Visualmedapp/">Visualmed: Clinical Trials</a> #cardiology #swanganz #rhc #Medtwitter
Diego Segura-Rodríguez (@seguracardio) 's Twitter Profile Photo

📌Practical Guidance for Hemodynamic Assessment by Right Heart Catheterization in Management of #HeartFailure Terrific review‼️ Make sure to share it‼️👇🏼 #RHC #PH #StateOfTheArt #Review

📌Practical Guidance for Hemodynamic Assessment by Right Heart Catheterization in Management of #HeartFailure 

Terrific review‼️
Make sure to share it‼️👇🏼
#RHC #PH #StateOfTheArt #Review
Sripal Bangalore (@sripalbangalore) 's Twitter Profile Photo

1. Interesting discus on guides w SH. I am in the no SH camp for any PCI. Yet to hear cogent argument for SH. Also surprised some use it in CTOs but not Ostial lesions and why the rationale should be different. Let’s break this down into coronary pressure, flow and contrast use.

Pablo Corral MD (@drpablocorral) 's Twitter Profile Photo

👉Managing Dyslipidemia in 2025: The Era of Precision Lipidology ☝️As we move through 2025, dyslipidemia management has clearly evolved beyond the traditional statin + ezetimibe approach. ☝️We now have an expanding armamentarium of targeted therapies addressing

👉Managing Dyslipidemia in 2025: The Era of Precision Lipidology

☝️As we move through 2025, dyslipidemia management has clearly evolved beyond the traditional statin + ezetimibe approach. 

☝️We now have an expanding armamentarium of targeted therapies addressing
Davide Capodanno (@dfcapodanno) 's Twitter Profile Photo

This State-of-the-Art review aims to facilitate a comprehensive assessment of plaque pathology using coronary imaging. It outlines how imaging characterizes plaque components and phenotypes, links plaque features to clinical events, and summarizes trials using serial imaging to

This State-of-the-Art review aims to facilitate a comprehensive assessment of plaque pathology using coronary imaging. It outlines how imaging characterizes plaque components and phenotypes, links plaque features to clinical events, and summarizes trials using serial imaging to
Diego Segura-Rodríguez (@seguracardio) 's Twitter Profile Photo

🕒 Your heart has a clock, too. ⚠️Circadian rhythms in cardiovascular disease 💤 🕰️ Chronotherapy could be the secret weapon in personalized care. 🧠🫀 #CircadianRhythms #Cardiology #MedTwitter #StateOfTheArt #Review

🕒 Your heart has a clock, too.

⚠️Circadian rhythms in cardiovascular disease 💤 

🕰️ Chronotherapy could be the secret weapon in personalized care.

🧠🫀 #CircadianRhythms #Cardiology #MedTwitter #StateOfTheArt #Review
EuroIntervention (@eurointerventio) 's Twitter Profile Photo

📢 NEW State-of-the-Art Review Advanced coronary imaging techniques—IVUS, OCT, NIRS, and CCTA—enable detailed assessment of plaque morphology, vulnerability, and therapeutic response. This comprehensive review by García-García et al. outlines current evidence and clinical

📢 NEW State-of-the-Art Review
Advanced coronary imaging techniques—IVUS, OCT, NIRS, and CCTA—enable detailed assessment of plaque morphology, vulnerability, and therapeutic response.
This comprehensive review by García-García et al. outlines current evidence and clinical
Diego Segura-Rodríguez (@seguracardio) 's Twitter Profile Photo

🧬Cardiac Channelopathies: A Silent Risk for Sudden Cardiac Death⚡️ Inherited disorders like this account for >50% of SCD cases in people <50. Dive into this #review👇 #Cardiology #Channelopathies #SuddenCardiacDeath

🧬Cardiac Channelopathies: A Silent Risk for Sudden Cardiac Death⚡️

Inherited disorders like this account for &gt;50% of SCD cases in people &lt;50.

Dive into this #review👇

#Cardiology #Channelopathies #SuddenCardiacDeath
PCRonline 🫀 (@pcronline) 's Twitter Profile Photo

Unusual coronary complications shared by your peers 🔗pcronline.com/Cases-resource… (access via your free My PCR account) Take a closer look at these rare coronary mishaps and the smart techniques that helped salvage the situation: trapped tools, ruptured balloons, and more.

Unusual coronary complications shared by your peers

🔗pcronline.com/Cases-resource…
(access via your free My PCR account)

Take a closer look at these rare coronary mishaps and the smart techniques that helped salvage the situation: trapped tools, ruptured balloons, and more.